US manufacturer cannot supply Wegovy injector pen syringes
Novo Nordisk will struggle to meet demand for its Wegovy injector pens during the first half of 2022.
by marketwire, translated by catherine brett
Novo Nordisk will have supply problems concerning its Wegovy injector pens during the first half of 2022 on the US market, the Danish pharmaceutical company reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
